Check-Cap (MBAI) Free Cash Flow Growth (3y) (2017 - 2024)
Check-Cap (MBAI) Free Cash Flow Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -7.47% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 53.76% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 14.16% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 23.11% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.89% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.16% |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -176.77% |
| Dec 31, 2023 | 49.45% |
| Sep 30, 2023 | 46.78% |
| Jun 30, 2023 | 56.38% |
| Mar 31, 2023 | 50.22% |
| Dec 31, 2022 | -76.84% |
| Sep 30, 2022 | -10.37% |
| Jun 30, 2022 | -27.82% |
| Mar 31, 2022 | -7.77% |
| Dec 31, 2021 | 55.58% |
| Sep 30, 2021 | 57.02% |
| Jun 30, 2021 | 85.98% |
| Mar 31, 2021 | -11.97% |
| Dec 31, 2020 | -81.24% |
| Sep 30, 2020 | -22.82% |
| Jun 30, 2020 | -0.07% |
| Mar 31, 2020 | -13.98% |
| Dec 31, 2019 | -23.11% |
| Sep 30, 2019 | -34.05% |
| Jun 30, 2019 | -3.52% |